市場調查報告書
商品編碼
1123092
蛋白質工程的全球市場:2022年~2028年Global Protein Engineering Market Research and Forecasts 2022-2028 |
在預測期內(2022-2028 年),全球蛋白質工程市場規模預計將以 12.5% 左右的顯著複合年增長率增長。蛋白質工程在農業化學工業中提供了巨大的機會,因為它可以產生功能增強的酶,從而促進作物產量和生物燃料的生產。它還有望作為實現必要作物產量增加以滿足未來需求的工具發揮重要作用。
本報告提供全球蛋白質工程市場相關調查,提供市場概要,以及蛋白質各類型,各產品,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。
全球蛋白質工程市場,蛋白質各類型
全球蛋白質工程市場,各產品
全球蛋白質工程市場,各終端用戶
Global Protein Engineering Market Size, Share & Trends Analysis Report by Technology (Rational Protein Design and Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), and Forecast 2022-2028
The global protein engineering market is anticipated to grow at a significant CAGR of around 12.5% during the forecast period (2022-2028). Protein engineering holds an immense opportunity in the agrochemical industry as engineering in proteins may lead to the generation of enzymes with an improved function that may increase the crop yield or facilitate biofuel production. It is also likely to play an important role as a tool to attain increased crop yield needed to meet future needs. Some methods are used for protein engineering such as site-directed mutagenesis, random mutagenesis, random mutagenesis, homology modeling, cell surface display technology, and DNA shuffling technology. Protein engineering has various applications as biocatalysts from medical, environmental to nanobiotechnology. The rising focus of pharmaceutical and biotechnology companies on research & development of protein-based drugs due to advantages over non-protein drugs, such as higher cost-effectiveness and improved patient outcomes are the major factors driving the market growth.
Moreover, the surging strategic collaborations among prominent players of market is another key factor for the market development. For instance, in Jan 2021 Zymvol Biomodelling, S.L collaborated with Aminoverse B.V, a biotech company specializing in enzyme discovery and design, to develop custom-made alcohol dehydrogenases, an enzyme most commonly used in the flavors and fragrances and the fine chemicals industry. Apart from these, increasing public and private investments in synthetic biology, and continuous advancements in protein engineering technologies are expected to offer new growth opportunities to the market during the forecast period.
Impact of COVID-19 Pandemic on Global Protein Engineering Market
The field of protein engineering is widely driven by research. For instance, amid COVID-19 pandemic, in March 2020, a team of scientists from North America found out that Protein mapping finds 69 potential treatments for COVID-19.
Segmental Outlook
The global protein engineering market is segmented based on protein type, product, and end-user. Based on technology, the market is sub-segmented into rational protein design and irrational protein design. Based on protein type, the market is sub-segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony-stimulating factor, coagulation factor, vaccines, and others. Among these, monoclonal antibodies segment is projected to register the fastest revenue growth rate in the global market over the projected period owing to the increasing R&D activities for advanced monoclonal antibodies. Based on product, the market is sub-segmented into instruments, service and software, and reagents. Based on end-user, the market is sub-segmented into academic research institutes, pharmaceutical and biotechnology companies, and CROs.
Global Protein Engineering Market Share by Protein Type, 2021 (%)
Global Parkinson Disease Drug Market Growth, by Region
Monoclonal Antibodies segment is expected to be the largest contributor in the global protein engineering market
Monoclonal antibodies are anticipated to hold the largest share over the forecast period owing to their high adoption for numerous therapies such as cancer and autoimmune diseases. The increasing prevalence of cancer and other autoimmune diseases has significantly increased the use of monoclonal bodies for the treatment of diseases. They also have tremendous applications in the fields of therapeutics, diagnostics, and targeted drug delivery systems for infectious diseases caused by viruses, bacteria, protozoa, and many more. Hence, recombinant deoxyribonucleic acid technology, through genetic engineering, has successfully led to the possibility of the reconstruction of monoclonal antibodies, which is the driving factor for the growth of the market.
Regional Outlook
The global protein engineering market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Global Protein Engineering Market, by Region 2022-2028
Global Protein Engineering Market, by Region
The Asia-Pacific region is estimated to hold a major share in the Global Protein Engineering Market
Asia-Pacific is expected to witness the fastest CAGR during the forecast period, due to the growing presence of contract research organizations, rising healthcare IT spending, and unprecedented evolution of the healthcare infrastructure and standards across the region. Growing demand for personalized medicine and strong R&D investments in proteomics-based drug discovery projects are also supplementing the growth of the protein engineering market. In addition, proteomics R&D initiatives coupled with significant funding for protein-based drug research and advancements in genomics in several Asia Pacific countries are likely to offer new growth opportunities to the market during the forecast period.
Major Players Outlooks
The major companies serving the global protein engineering market include AB SCIEX, LLC, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Waters Corp., GenScript Biotech Corp, Thermo Fisher Scientific Inc, General Electric Co, Eli Lilly and Co, and Novartis International AG and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches to stay competitive in the market. For instance, in January 2019, Amunix Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery and development of novel immune-oncology therapeutics entered into a licensing agreement with Merck for rights to develop therapeutics against an undisclosed target using Amunix's proprietary protease-triggered immune activator (ProTIA) technology platform. The powerful new platform technology enabled the rapid generation of tumor activatable cytokines, signaling peptides/proteins or immune cell engagers.
The report covers
Market value data analysis of 2022 and forecast to 2028
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global protein engineering market
Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market
Global Protein Engineering Market by Protein Type
Global Protein Engineering Market by Product
Global Protein Engineering Market by End-User
4.1.12 Academic Research Institutes
4.1.13 Pharmaceutical and Biotechnology Companies
4.1.14 Contract Research Organizations (CROs)
5.4.1 Latin America
5.4.2 Middle East and Africa
16.